Rex Hematology Oncology Associates-Blue Ridge — Raleigh, North Carolina

Rex Hematology Oncology Associates-Blue Ridge is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rex Hematology Oncology Associates-Blue Ridge has participated in 13 clinical trials with 9 currently active.

Therapeutic areas: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Sponsors: NRG Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rex Hematology Oncology Associates-Blue Ridge?

Rex Hematology Oncology Associates-Blue Ridge has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rex Hematology Oncology Associates-Blue Ridge conducted?

Rex Hematology Oncology Associates-Blue Ridge has 13 clinical trials on record, with 9 currently active. Their work covers Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant Neoplasm in the Bone.

Is Rex Hematology Oncology Associates-Blue Ridge accredited by Crixeo Health?

Yes — Rex Hematology Oncology Associates-Blue Ridge holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rex Hematology Oncology Associates-Blue Ridge?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.